Clinical data for participating patients with type 2 diabetes and hypertension*: N = 527.
| CHARACTERISTIC | NO. OF PATIENTS (%) |
|---|---|
| Sex | |
| • Male | 272 (51.6) |
| • Female | 255 (48.4) |
| Age, y | |
| • < 55 | 97 (18.4) |
| • 55–64 | 162 (30.7) |
| • 65–74 | 130 (24.7) |
| • ≥ 75 | 138 (26.2) |
| Systolic BP at target (< 130 mm Hg) | 175 (33.2) |
| Diastolic BP at target (< 80 mm Hg) | 342 (64.9) |
| BP at target (< 130/80 mm Hg) | 143 (27.1) |
| BMI > 30 | 249 (47.2) |
| Smoking status | |
| • Current | 57 (10.8) |
| • Past | 201 (38.1) |
| • Never | 232 (44.0) |
| • Unknown | 37 (7.0) |
| No. of comorbidities† and complications | |
| • 0 | 13 (2.5) |
| • 1–3 | 178 (33.8) |
| • 4–6 | 221 (41.9) |
| • ≥ 7 | 115 (21.8) |
BMI–body mass index, BP–blood pressure.
↵* Hypertension and type 2 diabetes considered to be the index conditions for these patients.
↵† Other morbidities were counted as comorbidities, with ischemic heart disease, dyslipidemia, metabolic syndrome, arthritis, and gastroesophageal reflux disease occurring in more than 20% of patients.